logo

Search studies

54 studies found

PRECISESADS: Cross Sectional Study & Inception Cohort
ELU-4-9E5405-1

The goal of this project is to use the power of OMICs, and bioinformatics to identify new classifications for diseases known to share common pathophysiological mechanisms. Such knowledge has not been applied to individual patients, depriving them of potential benefits in terms of the use of new therapeutic agents that are being developed for one disease but cannot be applied in another, due to current clinical classifications. We will investigate individuals with systemic lupus erythematosus ...

  • Types: Observational

PRECISESADS: Cross Sectional Study - Lupus patients ...
ELU-4-32DBAB-1

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Cross Sectional Study

  • Types: Observational

PSD-COVID19-OMICS
e6f87415-04f3-11ec-96d0-d0577bab103e

PSD COVID19 OMICS

  • Types: Psd Covid19 Omics

Pfizer (NCT02958865)
ELU-4-B16B4B-1

The Pfizer UC dataset represents baseline, placebo and treatment (PF-06700841) subject and sample-level data extracted from a phase 2 study in moderate to severe ulcerative colitis.

  • Types: Clinical Trial Ncit:c71104 Nct02958865

RHAPSODY Cohort 1
a6c83b0c-54c1-11eb-9562-acde48001122

fairplus stamp

  • Types: Risk And Progression Of Prediabetes And Type 2 Diabetes

RHAPSODY Cohort 10
8845e73c-90ed-11ed-ba1a-acde48001122

fairplus stamp

  • Types: Risk And Progression Of Prediabetes And Type 2 Diabetes

RHAPSODY Cohort 11
8845ec32-90ed-11ed-ba1a-acde48001122

fairplus stamp

  • Types: Risk And Progression Of Prediabetes And Type 2 Diabetes

RHAPSODY Cohort 2
8845880a-90ed-11ed-ba1a-acde48001122

fairplus stamp

  • Types: Risk And Progression Of Prediabetes And Type 2 Diabetes